Table 2 Candida spp. prevalence and activity of Candida enzymes isolated from the oral cavity in patients from the control group (C), with Nephrotic syndrome (NS), and with type 1 diabetes (D1)
From: Candida spp. and gingivitis in children with nephrotic syndrome or type 1 diabetes
Group | Candida spp. | Activity of Candida enzymes isolated from oral cavity | |||||||
|---|---|---|---|---|---|---|---|---|---|
Code E7 or E16 or E18 | Code E7 | Code E16 | Code E18 | ||||||
1-5 | 5 | 1-5 | 5 | 1-5 | 5 | 1-5 | 5 | ||
n/% | n | ||||||||
NS | 11/34.37 | 11/34.37 | 8/25.00 | 11 | 1 | 9 | 5 | 10 | 6 |
D1 | 8/22.86 | 7/20.0 | 6/17.14 | 7 | 0 | 7 | 4 | 9 | 4 |
C | 12/41.37 | 10/34.48 | 2/6.89 | 11 | 0 | 10 | 0 | 10 | 2 |
P-value - chi-squared test | |||||||||
NS vs C | 0.573 | 0.993 | 0.057 | 0.773 | 0.337 | 0.592 | 0.026* | 0.788 | 0.171 |
D1 vs C | 0.111 | 0.192 | 0.217 | 0.112 | 1.000 | 0.192 | 0.060 | 0.445 | 0.536 |